Abstract

ObjectiveTo determine the added value of qualitative analysis as an adjunct to quantitative analysis for the discrimination of benign and malignant lesions in patients with breast cancer using diffusion-weighted imaging (DWI) with readout-segmented echo-planar imaging (rs-EPI).MethodsA total of 99 patients with 144 lesions were reviewed from our prospectively collected database. DWI data were obtained using rs-EPI acquired at 3.0 T. The diagnostic performances of DWI in the qualitative, quantitative, and combination analyses were compared with that of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Additionally, the effect of lesion size on the diagnostic performance of the DWI combination analysis was evaluated.ResultsThe strongest indicators of malignancy on DWI were a heterogeneous pattern (P = 0.005) and an apparent diffusion coefficient (ADC) value <1.0 × 10–3 mm2/sec (P = 0.002). The area under the curve (AUC) values for the qualitative analysis, quantitative analysis, and combination analysis on DWI were 0.732 (95% CI, 0.651–0.803), 0.780 (95% CI, 0.703–0.846), and 0.826 (95% CI, 0.754–0.885), respectively (P<0.0001). The AUC for the combination analysis on DWI was superior to that for DCE-MRI alone (0.651, P = 0.003) but inferior to that for DCE-MRI plus the ADC value (0.883, P = 0.03). For the DWI combination analysis, the sensitivity was significantly lower in the size ≤1 cm group than in the size >1 cm group (80% vs. 95.6%, P = 0.034).ConclusionsQualitative analysis of tumor morphology was diagnostically applicable on DWI using rs-EPI. This qualitative analysis adds value to quantitative analyses for lesion characterization in patients with breast cancer.

Highlights

  • Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely used in breast cancer diagnosis and staging

  • The area under the curve (AUC) values for the qualitative analysis, quantitative analysis, and combination analysis on diffusion-weighted imaging (DWI) were 0.732, 0.780, and 0.826, respectively (P

  • Qualitative analysis of tumor morphology was diagnostically applicable on DWI using rsEPI

Read more

Summary

Introduction

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely used in breast cancer diagnosis and staging. DCE-MRI has widely demonstrated diagnostic value in breast imaging [1]. It provides high-resolution morphological information regarding the contrastenhanced characteristics of the lesions. DCE-MRI has a high sensitivity of 94–100%, the specificity is only 40–80% for the characterization of the breast [2,3,4]. In addition to this relatively low specificity, DCE-MRI is time consuming and expensive. It carries the risk of potential side effects from the contrast media. Non-contrast-enhanced imaging techniques have been actively investigated as alternatives or adjuncts to DCE-MRI to detect breast cancer [4,5,6,7,8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call